Filed July 20, 2021
`
`On behalf of Illumina, Inc.
`By: Kerry S. Taylor
`
`Nathanael R. Luman
`Michael L. Fuller
`William R. Zimmerman (pro hac vice)
`KNOBBE, MARTENS, OLSON & BEAR, LLP
`2040 Main Street, 14th Floor
`Irvine, CA 92614
`Fax: (858) 707-4001
`Tel.: (858) 707-4000
`Email: BoxIllumina@knobbe.com
`
`
`
`
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`__________________________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`__________________________________
`
`ILLUMINA, INC.
`Petitioner,
`
`v.
`
`TRUSTEES OF COLUMBIA UNIVERSITY
`IN THE CITY OF NEW YORK
`Patent Owner.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`IPR2020-00988
`Patent 10,407,458
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`ILLUMINA UPDATED EXHIBIT LIST
`
`
`
`
`
`On behalf of Illumina, Inc.
`By: Kerry S. Taylor
`
`Nathanael R. Luman
`Michael L. Fuller
`William R. Zimmerman (pro hac vice)
`KNOBBE, MARTENS, OLSON & BEAR, LLP
`2040 Main Street, 14th Floor
`Irvine, CA 92614
`Fax: (858) 707-4001
`Tel.: (858) 707-4000
`Email: BoxIllumina@knobbe.com
`
`
`
`
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`__________________________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`__________________________________
`
`ILLUMINA, INC.
`Petitioner,
`
`v.
`
`TRUSTEES OF COLUMBIA UNIVERSITY
`IN THE CITY OF NEW YORK
`Patent Owner.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`IPR2020-00988
`Patent 10,407,458
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`ILLUMINA UPDATED EXHIBIT LIST
`
`
`
`
`
`Illumina v. Columbia
`IPR2020-00988 – Patent 10,407,458
`
`
`
`Pursuant to 37 C.F.R. § 42.63(e), Petitioner Illumina, Inc., hereby provides
`
`an updated list of its exhibits in this proceeding.
`
`Exhibit
`No.
`
`EXHIBIT LIST
`
`Description
`
`1001
`
`U.S. Patent No. 10,407,458 (“Ju”) – (guanine with allyl proviso)
`
`Exhibit numbers 1002-1012 not used.
`
`1013
`
`U.S. Patent No. 7,790,869 (“Ju”)
`
`1014
`
`U.S. Patent No. 7,713,698 (“Ju”)
`
`1015
`
`U.S. Patent No. 8,088,575 (“Ju”)
`
`1016
`
`U.S. Patent No. 9,718,852 (“Ju”) – (adenine)
`
`1017
`
`U.S. Patent No. 9,719,139 (“Ju”) – (thymine)
`
`1018
`
`U.S. Patent No. 9,708,358 (“Ju”) – (cytosine)
`
`1019
`
`U.S. Patent No. 9,725,480 (“Ju”) – (guanine)
`
`1020
`
`U.S. Patent No. 9,868,985 (“Ju”) – (method)
`
`1021
`
`2014-03-06 IPR2012-00007, Paper 140, Final Written Decision
`
`1022
`
`2014-03-06 IPR2012-00006, Paper 128, Final Written Decision
`
`1023
`
`2014-03-06 IPR2013-00011, Paper 130, Final Written Decision
`
`1024
`
`2019-06-21 IPR2018-00291, -00318, -00322, -00385, Final Written
`Decisions
`
`1025
`
`Exhibit number not used
`
`1026
`
`Exhibit number not used
`
`1027
`
`Exhibit number not used
`
`- 1 -
`
`
`
`Illumina v. Columbia
`IPR2020-00988 – Patent 10,407,458
`
`Exhibit
`No.
`
`Description
`
`1028
`
`2019-09-09 IPR2018-00797, Final Written Decision
`
`1029
`
`2015-07-17 Federal Circuit Opinion Affirming IPR2012-00006,
`IPR2012-00007 and IPR2013-00011
`
`1030
`
`U.S. Patent No. 5,547,839 (“Dower”)
`
`1031 WO 91/06678 (“Tsien”)
`
`1032
`
`1033
`
`1034
`
`1035
`
`1036
`
`1037
`
`Excerpt from Prosecution History of U.S. Patent No. 10,407,458
`(Declaration of Jingyue Ju and Accompanying Documents)
`
`Welch et al., “Syntheses of Nucleosides Designed for Combinatorial
`DNA Sequencing,” Chem. Eur. J., 5:951-960 (1999) (“Welch”)
`
`Excerpt from Prosecution History of U.S. Patent No. 10,407,458 (2019-
`01-16 Pre-interview First Office Action)
`
`Excerpt from Prosecution History of U.S. Patent No. 10,407,458 (2019-
`02-12 Applicant Arguments/Remarks Made in an Amendment)
`
`Excerpt from Prosecution History of U.S. Patent No. 10,407,458 (2019-
`05-09 Applicant Arguments/Remarks Made in an Amendment)
`
`Alberts et al., “Molecular Biology of the Cell,” Third Edition, Garland
`Publishing Inc., New York (1994)
`
`1038
`
`Declaration of Dr. Floyd Romesberg, Ph.D.
`
`1039
`
`Metzker et al., “Termination of DNA synthesis by novel 3’-modified-
`deoxyribonucleoside 5’-triphosphates,” Nucleic Acids Research,
`22:4259-67 (1994) (“Metzker”)
`
`1040
`
`Sanger et al., “DNA sequencing with chain-terminating inhibitors,”
`Proc. Nat’l Acad. Sci. USA, 74:5463-5467 (1977) (“Sanger”)
`
`1041
`
`Prober et al., “A System for Rapid DNA Sequencing with Fluorescent
`Chain-Terminating Dideoxynucleotides,” Science, 238:336-341 (1987)
`(“Prober”)
`
`- 2 -
`
`
`
`Illumina v. Columbia
`IPR2020-00988 – Patent 10,407,458
`
`Exhibit
`No.
`
`Description
`
`1042
`
`U.S. Patent No. 5,302,509 (“Cheeseman”)
`
`1043
`
`U.S. Patent No. 5,763,594 (“Hiatt”)
`
`1044
`
`Pelletier et al., “Structures of Ternary Complexes of Rat DNA
`Polymerase β, a DNA Template-Primer, and ddCTP,” Science,
`264:1891-1903 (1994) (“Pelletier”)
`
`1045
`
`U.S. Patent No. 4,804,748 (“Seela Patent”)
`
`1046
`
`Rosenblum et al., “New dye-labeled terminators for improved DNA
`sequencing patterns,” Nucleic Acid Research, 25:4500-4504 (1997)
`(“Rosenblum”)
`
`1047
`
`Exhibit number not used
`
`1048
`
`1049
`
`1050
`
`Excerpts from 2019-01-14 Deposition Transcript of Dr. Menchen in
`IPR2018-00291, -00318, -00322, and -00797
`
`2018-05-04 IPR2018-00385, Paper 13, Patent Owner Preliminary
`Response
`
`Canard et al., “Catalytic editing properties of DNA polymerases,” Proc.
`Nat’l Acad. Sci. USA, 92:10859-10863 (1995) (“Canard”)
`
`1051
`
`Exhibit number not used
`
`1052
`
`Yu et al., “Cyanine dye dUTP analogs for enzymatic labeling of DNA
`probes,” Nucleic Acids Research, 22:3226-3232 (1994) (“Yu”)
`
`1053
`
`Livak et al., “Detection of single base differences using biotinylated
`nucleotides with very long linker arms,” Nucleic Acids Research,
`20:4831-4837 (1992) (“Livak”)
`
`1054
`
`Stryer, “Biochemistry,” Fourth Edition, W.H. Freeman and Co., New
`York (1995) (“Stryer”)
`
`- 3 -
`
`
`
`Illumina v. Columbia
`IPR2020-00988 – Patent 10,407,458
`
`Exhibit
`No.
`
`1055
`
`Description
`
`Watson & Crick, “Genetical Implication of the Structure of
`Deoxyribonucleic Acid,” Nature, 171:964-967 (1953) (“Watson &
`Crick”)
`
`1056
`
`U.S. Patent No. 5,151,507 (“Hobbs”)
`
`1057
`
`Seela et al., “Oligonucleotide Duplex Stability Controlled by the 7-
`Substituents of 7-Deazaguanine Bases,” Bioorganic & Mechanical
`Chemistry Letters, 5:3049-3052 (1995) (“Seela 1995”)
`
`1058
`
`Excerpts from Sept. 4-5, 2013 Deposition Transcript of Dr. George L.
`Trainor in IPR2012-00007
`
`1059
`
`Exhibit number not used
`
`1060
`
`Hovinen et al., “Synthesis of 3´-O-(ω-Aminoalkoxymethyl)thymidine
`5´-Triphosphates, Terminators of DNA Synthesis that Enable 3’-
`Labeling,” J. Chem. Soc. Perkin Trans. 1, 211-217 (1994) (“Hovinen”)
`
`1061
`
`Exhibit number not used
`
`1062
`
`Excerpt from Prosecution History of U.S. Patent No. 9,725,480
`
`1063
`
`Ireland et al., “Approach to the Total Synthesis of Chlorothricolide:
`Synthesis of (±)-19,20-Dihydro-24-O-methylchlorothricolide, Methyl
`Ester, Ethyl Carbonate,” J. Org. Chem. 51:635-648 (1986) (“Ireland”)
`
`1064
`
`Exhibit number not used
`
`1065
`
`Excerpt from Prosecution History of U.S. Patent No. 10,428,380 [U.S.
`Appl. No. 16/150,191] (2019-03-12 Pre-interview first office action)
`
`1066
`
`1067
`
`Ruparel et al., “Design and synthesis of a 3´-O-allyl photocleavable
`fluorescent nucleotide as a reversible terminator for DNA sequencing
`by synthesis,” PNAS, Vol. 102, No. 17, 5932-37 (2005) (“Ruparel”)
`
`Ju et al., “Four-color DNA sequencing by synthesis using cleavable
`fluorescent nucleotide reversible terminators,” PNAS, Vol. 103, No.
`52, 19635-40 (2006) (“Ju”)
`
`- 4 -
`
`
`
`Illumina v. Columbia
`IPR2020-00988 – Patent 10,407,458
`
`Exhibit
`No.
`
`Description
`
`1068
`
`2015-02-11 IPR2013-00517, Paper 87, Final Written Decision
`
`1069
`
`2016-05-09 Federal Circuit Opinion Affirming IPR2013-00517
`
`1070
`
`U.S. Patent No. 5,449,767 (“Ward”)
`
`1071
`
`Ramzaeva et al., “88. 7-Substituted 7-Deasa-2’-deoxyguanosines:
`Regioselective Halogenation of Pyrrolo[2,3-d] pyrimidine
`Nucleosides,” Helvetica Chimica Acta, 78:1083-1090 (1995)
`(“Ramzaeva 1995”)
`
`1072 WO 98/33939 (“Anazawa”)
`
`1073
`
`Anazawa (English Translation of WO 98/33939)
`
`1074 WO 89/11548 (“Saiki”)
`
`1075
`
`PROTECTIVE GROUPS IN ORGANIC SYNTHESIS (Theodora W.
`Greene & Peter G.M. Wuts eds., 3rd ed. 1999) (excerpts) (“Greene &
`Wuts”)
`
`1076
`
`Boss et al., “Cleavage of Allyl Ethers with Pd/C,” Angew. Chem. Int.
`Ed. Engl., 15:558-559 (1976) (“Boss”)
`
`1077
`
`1078
`
`Qian et al., “Unexpected Enzymatic Fucosylation of the Hindered
`Tertiary Alcohol of 3-C-Methyl-N-Acetyllactosamine Produces a
`Novel Analogue of the LeX-Trisaccharide,” J. Am. Chem. Soc.,
`120:2184-2185 (1998) (“Qian”)
`
`Kamal et al., “A Mild and Rapid Regeneration of Alcohols from their
`Allylic Ethers by Chlorotrimethylsilane/Sodium Iodide,” Tetrahedron
`Letters, 40:371-372 (1999) (“Kamal”)
`
`1079
`
`2014-07-25 Final Written Decision in IPR2013-00128, Paper 92
`
`1080
`
`2014-10-28 Final Written Decision in IPR2013-00266, Paper 73
`
`1081
`
`2016-01-29 Federal Circuit Opinion Affirming IPR2013-00128 and
`IPR2013-00266
`
`- 5 -
`
`
`
`Illumina v. Columbia
`IPR2020-00988 – Patent 10,407,458
`
`Exhibit
`No.
`
`Description
`
`1082
`
`IPR2017-02172, Paper 20 (P.T.A.B. 2018)
`
`1083
`
`IPR2017-02174, Paper 20 (P.T.A.B. 2018)
`
`1084
`
`1085
`
`Meng et al., “Design and Synthesis of a Photocleavable Fluorescent
`Nucleotide 3´-O-Allyl-dGTP-PC-Bodipy-FL-510 as a Reversible
`Terminator for DNA Sequencing by Synthesis,” J. Org. Chem. 71,
`3248-3252 (2006) (“Meng”)
`
`Bi et al., “Design and Synthesis of a Chemically Cleavable Fluorescent
`Nucleotide, 3´-O-Allyl-dGTP-allyl-Bodipy-FL-510, as a Reversible
`Terminator for DNA Sequencing by Synthesis,” J. Am. Chem. Soc.,
`128, 2542-2543 (2006) (“Bi”)
`
`1086
`
`Meng thesis from Dr. Ju’s laboratory at Columbia University (2006)
`(“Meng Thesis”)
`
`1087
`
`1088
`
`1089
`
`1090
`
`1091
`
`Wu, et al., “3´-O-modified nucleotides as reversible terminators for
`pyrosequencing,” PNAS, Vol. 104, No. 42, 16462-16467 (2007)
`(“Wu”)
`
`Kim thesis from Dr. Ju’s laboratory at Columbia University (2008)
`(“Kim Thesis”)
`
`Wu thesis from Dr. Ju’s laboratory at Columbia University (2008)
`(“Wu Thesis”)
`
`Zhang thesis from Dr. Ju’s laboratory at Columbia University (2008)
`(“Zhang Thesis”)
`
`Guo et al., “Four-color DNA sequencing with 3´-O-modified
`nucleotide reversible terminators and chemically cleavable fluorescent
`dideoxynucleotides,” PNAS, Vol. 105, No. 27, 9145-9150 (2008)
`(“Guo”)
`
`1092
`
`Guo thesis from Dr. Ju’s laboratory at Columbia University (2009)
`(“Guo Thesis”)
`
`- 6 -
`
`
`
`Illumina v. Columbia
`IPR2020-00988 – Patent 10,407,458
`
`Exhibit
`No.
`
`1093
`
`1094
`
`1095
`
`Description
`
`Yu thesis from Dr. Ju’s laboratory at Columbia University (2010) (“Yu
`Thesis”)
`
`Qui thesis from Dr. Ju’s laboratory at Columbia University (2011)
`(“Qui Thesis”)
`
`Seela et al., “Duplex Stability of Oligonucleotides Containing 7-
`Substituted 7-Deaza- and 8-Aza-7-Deazapurine Nucleosides,”
`Nucleosides & Nucleotides, 16(7-9), 963-966, 1997 (“Seela 1997”)
`
`1096
`
`Lipshutz et al., “Hydrolysis of Acetals and Ketals Using LiBF4,”
`Synthetic Communications, 12:4, 267-277 (1982)
`
`1097
`
`Curriculum Vitae of Floyd Romesberg, Ph.D.
`
`1098
`
`List of documents considered by Floyd Romesberg, Ph.D.
`
`1099
`
`U.S. Patent No. 7,270,951 (“Stemple”)
`
`1100
`
`Kraevskii et al., Molecular Biology 21:25-29 (1987) (“Kraevskii”)
`
`1101
`
`Seela et al., “7-Deazapurine containing DNA,” Nucleic Acids
`Research, 20:55-61 (1991) (“Seela 1991”)
`
`1102
`
`1103
`
`1104
`
`Sears et al., “CircumVent Thermal Cycle Sequencing and Alternative
`Manual and Automated DNA Sequencing Protocols Using the Highly
`Thermostable VentR (exo) DNA Polymerase,” BioTechniques, 13:626-
`633 (1992) (“Sears”)
`
`Ramzaeva et al., “123. 7-Deazaguanine DNA: Oligonucleotides with
`Hydrophobic or Cationic Side Chains,” Helvetica Chimica Acta,
`80:1809-1822 (1997) (“Ramzaeva 1997”)
`
`Seitz et al., HYCRON, an Allylic Anchor for High-Efficiency Solid
`Phase Synthesis of Protected Peptides and Glycopeptides,” J. Org.
`Chem., 62:813-826 (1997) (“Seitz”)
`
`- 7 -
`
`
`
`Illumina v. Columbia
`IPR2020-00988 – Patent 10,407,458
`
`Exhibit
`No.
`
`Description
`
`1105
`
`1106
`
`1107
`
`1108
`
`1109
`
`1110
`
`1111
`
`1112
`
`1113
`
`1114
`
`1115
`
`Greenberg et al., “Optimization and Mechanistic Analysis of
`Oligonucleotide Cleavage from Palladium-Labile Solid-Phase
`Synthesis Supports,” J. Org. Chem., 63:4062-4068 (1998)
`(“Greenberg”)
`
`Guillier et al., “Linkers and Cleavage Strategies in Solid-Phase Organic
`Synthesis and Combinatorial Chemistry,” Chem. Rev., 100:2091-2157
`(2000) (“Guillier Review 2000”)
`
`Fields, Methods in Molecular Biology, Volume 35, Peptide Synthesis
`Protocols, Chapter 2, Humana Press 1994 (“Fields”)
`
`Gigg et al., “The Allyl Ether as a Protecting Group in Carbohydrate
`Chemistry Part II”, J. Chem. Soc. (C), 1903-1911 (1968) (“Gigg”)
`
`IUPAC, Nomenclature of Organic Chemistry, Eds. Rigaudy et al.,
`International Union of Pure and Applied Chemistry, Organic Chemistry
`Division, Commission on Nomenclature of Organic Chemistry,
`Pergamon Press, 1979.
`
`CRC Handbook of Chemistry and Physics, eds. Weast et al., 72nd
`edition, CRC Press (1991)
`
`McGraw-Hill Dictionary of Chemistry, ed. Parker, McGraw-Hill Book
`Co., 1984
`
`Vollhardt et al., “Organic Chemistry,” W.H. Freeman and Co., New
`York (2d ed. 1994) (“Vollhardt”)
`
`Solomons, “Organic Chemistry”, Fourth Edition, John Wiley & Sons
`(1988) (“Solomons”)
`
`Morrison et al., “Organic Chemistry,” Third Edition, Allyn and Bacon,
`Inc. (1973)
`
`Dominguez et al., “DNA polymerase mu (Pol μ), homologous to TdT,
`could act as a DNA mutator in eukaryotic cells,” The EMBO Journal,
`19(7): 1731-1742 (2000) (“Dominguez”)
`
`- 8 -
`
`
`
`Illumina v. Columbia
`IPR2020-00988 – Patent 10,407,458
`
`Exhibit
`No.
`
`Description
`
`1116
`
`Ito et al., “Compilation and alignment of DNA polymerase sequences,”
`Nucleic Acids Research, 19: 4045-4057 (1991) (“Ito”)
`
`1117
`
`1118
`
`1119
`
`1120
`
`1121
`
`1122
`
`1123
`
`Collins et al., “A rapid method for mRNA detection in single-cell
`Biopsies from preimplantation-stage bovine embryos,”
`Theriogenology, 43: 1227-1238 (1995) (“Collins”)
`
`Haber et al., “Diagnosis of Flame Chlorosis by Reverse Transcription–
`Polymerase Chain Reaction (RT-PCR),” Plant Disease, 79(6): 626-630
`(1995) (“Haber”)
`
`Sidorova et al., “A rapid RT-PCR based method for the detection of
`BCR-ABL translocation,” J. Clin Pathol: Mol Pathol 50: 266-268
`(1997) (“Sidorova”)
`
`Stromskaya et al., “Cell-specific effects of RAS oncogene and protein
`kinase C agonist TPA on P-glycoprotein function,” FEBS Letters, 368:
`373-376 (1995) (“Stromskaya”)
`
`Bechtereva et al., “DNA sequencing with thermostable Tet DNA
`polymerase from Thermus thermophilus,” Nucleic Acids Research, 17:
`10507 (1989) (“Bechtereva”)
`
`Asakura et al., “Cloning, Nucleotide Sequence, and Expression in
`Escherichia coli of DNA Polymerase Gene (polA) from Thermus
`thermophilus HB8,” Journal of Fermentation and Bioengineering,
`76(4): 265-269 (1993) (“Asakura”)
`
`Ikeda et al., “A Non-radioactive DNA Sequencing Method Using
`Biotinylated Dideoxynucleoside Triphosphates and ΔTth DNA
`Polymerase,” DNA Research, 2: 225-227 (1995) (“Ikeda”)
`
`1124 William R. Zimmerman Declaration in support of pro hac vice motion
`
`Exhibit numbers 1125-1145 not used.
`
`- 9 -
`
`
`
`Illumina v. Columbia
`IPR2020-00988 – Patent 10,407,458
`
`Exhibit
`No.
`
`Description
`
`1146
`
`1147
`
`1148
`
`1149
`
`1150
`
`1151
`
`1152
`
`1153
`
`1154
`
`Stipulated Extension of Time #1, The Trustees of Columbia University
`in the City of New York and Qiagen Sciences, LLC v. Illumina, Inc.,
`D.I. 7, 19-cv-01681 (D. Del.) (Sept. 19, 2019)
`
`Stipulated Extension of Time #2, The Trustees of Columbia University
`in the City of New York and Qiagen Sciences, LLC v. Illumina, Inc.,
`D.I. 31, 19-cv-01681 (D. Del.) (Mar. 20, 2020)
`
`Stipulated Extension of Time #3, The Trustees of Columbia University
`in the City of New York and Qiagen Sciences, LLC v. Illumina, Inc.,
`D.I. 34, 19-cv-01681 (D. Del.) (Apr. 15, 2020)
`
`Stipulated Extension of Time #4, The Trustees of Columbia University
`in the City of New York and Qiagen Sciences, LLC v. Illumina, Inc.,
`D.I. 39, 19-cv-01681 (D. Del.) (May 20, 2020)
`
`Stipulated Extension of Time #5, The Trustees of Columbia University
`in the City of New York and Qiagen Sciences, LLC v. Illumina, Inc.,
`D.I. 45, 19-cv-01681 (D. Del.) (Jun. 25, 2020)
`
`Stipulated Extension of Time #6, The Trustees of Columbia University
`in the City of New York and Qiagen Sciences, LLC v. Illumina, Inc.,
`D.I. 50, 19-cv-01681 (D. Del.) (Jul. 14, 2020)
`
`Stipulated Extension of Time #7, The Trustees of Columbia University
`in the City of New York and Qiagen Sciences, LLC v. Illumina, Inc.,
`D.I. 65, 19-cv-01681 (D. Del.) (Oct. 2, 2020)
`
`Docket, The Trustees of Columbia University in the City of New York
`and Qiagen Sciences, LLC v. Illumina, Inc., 19-cv-01681 (D. Del.)
`(current as of Oct. 7, 2020)
`
`Scheduling Order, The Trustees of Columbia University in the City of
`New York and Qiagen Sciences, LLC v. Illumina, Inc., D.I. 17, 19-cv-
`01681 (D. Del.) (Dec. 11, 2019)
`
`- 10 -
`
`
`
`Illumina v. Columbia
`IPR2020-00988 – Patent 10,407,458
`
`Exhibit
`No.
`
`Description
`
`1155
`
`1156
`
`1157
`
`1158
`
`1159
`
`1160
`
`1161
`
`1162
`
`1163
`
`Standing Order Regarding Criminal and Civil Jury Selections; Jury
`Trials; And Transition to Phase 2, In re: Court Operations Under the
`Exigent Circumstances Created by COVID-19 (D. Del.) (Sept. 1, 2020)
`
`Claim Construction Order, The Trustees of Columbia University in the
`City of New York and Qiagen Sciences, LLC v. Illumina, Inc., D.I. 60,
`19-cv-01681 (D. Del.) (Sept. 10, 2020)
`
`Joint Claim Construction Brief, The Trustees of Columbia University in
`the City of New York and Qiagen Sciences, LLC v. Illumina, Inc., D.I.
`54, 19-cv-01681 (D. Del.) (Aug. 10, 2020)
`
`Joint Claim Construction Appendix, The Trustees of Columbia
`University in the City of New York and Qiagen Sciences, LLC v.
`Illumina, Inc., D.I. 55, 19-cv-01681 (D. Del.) (Aug. 10, 2020)
`
`Columbia’s Motion for Reconsideration of the Court’s Claim
`Construction Order, The Trustees of Columbia University in the City of
`New York and Qiagen Sciences, LLC v. Illumina, Inc., D.I. 63, 19-cv-
`01681 (D. Del.) (Sept. 16, 2020)
`
`Illumina’s Answer to Columbia’s Motion for Reconsideration of the
`Court’s Claim Construction Order, The Trustees of Columbia
`University in the City of New York and Qiagen Sciences, LLC v.
`Illumina, Inc., D.I. 64, 19-cv-01681 (D. Del.) (Sept. 30, 2020)
`
`Transcript of Markman Hearing on Claim Construction, The Trustees
`of Columbia University in the City of New York and Qiagen Sciences,
`LLC v. Illumina, Inc., 19-cv-01681 (D. Del.) (Sept. 2, 2020)
`
`Columbia’s Claim Construction Presentation for Markman Hearing,
`The Trustees of Columbia University in the City of New York and
`Qiagen Sciences, LLC v. Illumina, Inc., 19-cv-01681 (D. Del.) (Sept. 2,
`2020)
`
`Illumina’s Claim Construction Presentation for Markman Hearing, The
`Trustees of Columbia University in the City of New York and Qiagen
`Sciences, LLC v. Illumina, Inc., 19-cv-01681 (D. Del.) (Sept. 2, 2020)
`
`- 11 -
`
`
`
`Illumina v. Columbia
`IPR2020-00988 – Patent 10,407,458
`
`Exhibit
`No.
`
`1164
`
`1165
`
`1166
`
`Description
`
`Columbia’s Motion to Take Judicial Notice of Documents Filed in
`IPR2020-00988, The Trustees of Columbia University in the City of
`New York v. Illumina, Inc., D.I. 51, 19-2302 (Fed. Cir.) (Sept. 16,
`2020)
`
`Illumina’s Opposition to Columbia’s Motion to Take Judicial Notice of
`Documents Filed in IPR2020-00988, The Trustees of Columbia
`University in the City of New York v. Illumina, Inc., D.I. 53, 19-2302
`(Fed. Cir.) (Sept. 25, 2020)
`
`Columbia’s Reply to Illumina’s Opposition to Columbia’s Motion to
`Take Judicial Notice of Documents Filed in IPR2020-00988, The
`Trustees of Columbia University in the City of New York v. Illumina,
`Inc., D.I. 54 19-2302 (Fed. Cir.) (Oct. 2, 2020)
`
`1167
`
`Exhibit number not used.
`
`1168
`
`Exhibit number not used.
`
`1169
`
`[Confidential] Settlement agreement
`
`
`
`
`Dated: July 20, 2021
`
`
`
`
`
`Respectfully submitted,
`
`By: /Kerry Taylor/
`Kerry Taylor (Reg. No. 43,947)
`Nathanael R. Luman (Reg. No. 63,160)
`Michael L. Fuller (Reg. No. 36,516)
`William R. Zimmerman (pro hac vice)
`KNOBBE, MARTENS, OLSON & BEAR, LLP
`Attorneys for Petitioner
`ILLUMINA, INC.
`
`
`
`- 12 -
`
`
`
`Illumina v. Columbia
`IPR2020-00988 – Patent 10,407,458
`
`CERTIFICATE OF SERVICE
`
`I hereby certify that true and correct copies of the foregoing ILLUMINA
`
`UPDATED EXHIBIT LIST and EXHIBIT 1169 are being served on July 20,
`
`2021, via email, pursuant to agreement of the parties, to counsel for the Trustees of
`
`Columbia University in the City of New York, at the email addresses below:
`
`John P. White
`jwhite@cooperdunham.com
`Gary J. Gershik
`ggershik@cooperdunham.com
`ColumbiaIPR@cooperdunham.com
`Cooper & Dunham, LLP
`30 Rockefeller Plaza, 20th Floor
`New York, NY 10112
`
`
`John D. Murnane
`VENABLE LLP
`jmurnane@venable.com
`1290 Avenue of the Americas
`New York, NY 10104
`
`Justin J. Oliver
`VENABLE LLP
`joliver@venable.com
`600 Massachusetts Ave.
`Washington, D.C. 20001
`
`
`
`
`
`Dated: July 20, 2021
`
`
`
`Respectfully submitted,
`
`
`
`By: /Kerry Taylor/
`Kerry Taylor (Reg. No. 43,947)
`Nathanael R. Luman (Reg. No. 63,160)
`Michael L. Fuller (Reg. No. 36,516)
`William R. Zimmerman (pro hac vice)
`KNOBBE, MARTENS, OLSON & BEAR, LLP
`Attorneys for Petitioner
`ILLUMINA, INC.
`
`53810348
`
`
`
`
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
